Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
The Analyst|January 27, 2026
Quantification of buparlisib in human liver microsomes employing an ultra-fast, sensitive UPLC-MS/MS method: <i>in vitro</i> and <i>in silico</i> metabolic stability evaluationMohamed W Attwa, Haitham AlRabiah, Ali S Abdelhameed, et al.
Food Chemistry|December 4, 2014
Spatial localisation of curcumin and rapid screening of the chemical compositions of turmeric rhizomes (Curcuma longa Linn.) using Direct Analysis in Real Time-Mass Spectrometry (DART-MS)A F M Motiur Rahman, Rihab F Angawi, Adnan A Kadi
The Analyst|November 13, 2025
Determination of veliparib metabolic stability in the human liver microsomes using a hydrophilic interaction UPLC-MS/MS quantitative method: greenness assessment with an <i>in silico</i> study for ADME, DEREK alarms and metabolic labilityMohamed W Attwa, Ali S Abdelhameed, Haitham AlRabiah, et al.
Analytical Methods : Advancing Methods and Applications|September 8, 2025
Assessment of the metabolic stability of avapritinib in human liver microsomes using a fast and green UPLC-MS/MS method: screening for structural alarms associated with metabolic lability and <i>in silico</i> toxicityMohamed W Attwa, Ali S Abdelhameed, Haitham AlRabiah, et al.
Frontiers in Chemistry|October 11, 2024
Assessment of the <i>in vitro</i> metabolic stability of CEP-37440, a selective FAK/ALK inhibitor, in HLMs using fast UPLC-MS/MS method: <i>in silico</i> metabolic lability and DEREK alerts screeningMohamed W Attwa, Haitham AlRabiah, Ali S Abdelhameed, et al.
Plos One|April 5, 2019
Validated LC-MS/MS assay for quantification of the newly approved tyrosine kinase inhibitor, dacomitinib, and application to investigating its metabolic stabilityAli S Abdelhameed, Adnan A Kadi, Mohamed W Attwa, et al.
Chemistry Central Journal|May 3, 2018
Development and validation of an HPLC-MS/MS method for the determination of arginine-vasopressin receptor blocker conivaptan in human plasma and rat liver microsomes: application to a metabolic stability studyHaitham Alrabiah, Adnan A Kadi, Mohamed W Attwa, et al.
Clinical Hemorheology and Microcirculation|July 21, 2007
Potential relation between cytoskeleton reorganization and e-NOS activity in sheared endothelial cells (Effect of rate and time of exposure)A Kadi, N de Isla, P Lacolley, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 20, 2018
Investigation of metabolic stability of the novel ALK inhibitor brigatinib by liquid chromatography tandem mass spectrometryHany W Darwish, Adnan A Kadi, Mohamed W Attwa, et al.
Chemistry Central Journal|December 24, 2017
LC-MS/MS method for the quantification of masitinib in RLMs matrix and rat urine: application to metabolic stability and excretion rateSawsan M Amer, Adnan A Kadi, Hany W Darwish, et al.
Pageof 15